Ex-Viatris Chief Sandeep Rao joins Solara Active Pharma Sciences as MD, CEO

Published On 2025-02-24 10:52 GMT   |   Update On 2025-02-24 10:52 GMT

Solara Active Pharma Sciences Limited has announced the appointment of Sandeep Rao as an Additional Director - Managing Director (MD) and Chief Executive Officer (CEO) on the Board of Directors of the Company for a term of 3 (three) years subject to approval of the Shareholders of the Company. The previous CEO, MD of the organisation, Poorvank Purohit resigned due to personal reasons. 

In addition, the Company has appointed Sarat Kumar as a Chief Financial Officer (“CFO”) and designated him as Key Managerial Personnel (“KMP”).

Furthermore, Vishal Mathur has also been appointed as the Chief Business Officer (CBO) in the capacity of Senior Managerial Personnel of the Company.  

Sandeep Rao has a rich career experience of 25+ years characterized by strategic growth - oriented thinking, focus on finding value creating opportunities, managing talented and high-performance teams, relentless execution and partnership management. Prior to this, Sandeep worked as CEO of Tenshi Pharma. Before this, Sandeep was Vice President and Head of Business Development for Emerging Markets with Viatris. Prior to Viatris, he was with the Biocon group for 16 years, the last position held being Senior Vice President and Head of the Insulins business.

Sarat Kumar has more than 18+ years of experience in leading Finance function for different Business Units/ Geographies across diverse sectors – Pharmaceuticals (Strides Pharma Science Limited), Biologics CDMO (BioCina), Power (Torrent Power), Oil & Gas (Shell Plc.) and has considerable experience in P&L performance tracking, Strategy formulation & implementation, and change management projects. In his past roles, Sarat has also led Global cross functional teams and delivered bottom line impacts through cost leadership and optimization projects. He has taken up additional cross-functional responsibilities in the Organization along with his Finance partnering role in the functions of Sales and Operations Planning, Manufacturing Planning, and Supply Chain management.

Vishal Mathur has around 25 years of experience and has expertise in API business expansion along with profitability improvement. In his recent role as Chief Commercial Officer and MC Member with Cohance Lifesciences between 2023 – 2024, Mr. Vishal had P&L ownership of $160M business and delivered 14% growth across APIs, Intermediates and PFIs. Prior to this, Mr. Vishal was Executive VP and Chief Marketing Officer with the API division of Emcure during 2021 - 2023. Prior to Emcure, he was with the Glenmark Lifesciences for 16 years, the last position held being VP – Sales & Marketing.

Read also: USFDA concludes inspection at Solara Active Pharma Sciences Vizag facility with Zero 483 inspectional observations

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News